Skip to content
Midomafetamine
Midomafetamine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
27 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Post-traumatic stress disordersD013313EFO_0001358F43.1—8———8
NeoplasmsD009369C80—1———1
Anxiety disordersD001008EFO_0006788F41.1—1———1
Combat disordersD003130—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Substance-related disordersD019966EFO_0003890F135———16
Healthy volunteers/patients—6————6
Amphetamine-related disordersD019969EFO_0004701F154———15
Mood disordersD019964EFO_0004247F30-F393———14
Social cognitionD0000832821————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes insipidusD003919E23.2————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMIDOMAFETAMINE
INNmidomafetamine
Description
3,4-methylenedioxymethamphetamine is a member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5. It has a role as a neurotoxin. It is a member of amphetamines and a member of benzodioxoles.
Classification
Small molecule
Drug classamfetamine derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CNC(C)Cc1ccc2c(c1)OCO2
Identifiers
PDB—
CAS-ID42542-10-9
RxCUI—
ChEMBL IDCHEMBL43048
ChEBI ID1391
PubChem CID1615
DrugBankDB01454
UNII IDKE1SEN21RM (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 14 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
529 adverse events reported
View more details